BioSpace News Archive

Lyndra Therapeutics, today announced that members of its management team will present and host one-on-one meetings at the 33rd Annual Piper Sandler Virtual Healthcare Conference taking place November 30 through December 2, 2021.

Otsuka America Pharmaceutical, Inc., acknowledges the importance of the favorable opinion of Otsuka’s Hospital Free Trial Program by the Department of Health and Human Services Office of Inspector General, which provides guidance for the design of manufacturer inpatient free trial programs that provide long-acting anti-psychotic injectable products for the treatment of serious mental illness in a hospital setting.

ViewRay, Inc. announced the pricing of an underwritten public offering of 12,500,000 shares of common stock at a price to the public of $5.60 per share, for gross proceeds of $70 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by ViewRay.